Elena Fonseca

Dr. Elena Fonseca

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2020 in Acta Neurologica Scandinavica
Verified
Journal Article
Closed access
PDF file
EFElena Fonseca
Elena Fonseca
MQManuel Quintana
Manuel Quintana
SLSofía Lallana
Sofía Lallana
JRJuan Luis Restrepo
Juan Luis Restrepo
LALaura Abraira
Laura Abraira
MTManuel Toledo
Manuel Toledo

18 October 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
ACAmanda Cano
Amanda Cano
EFElena Fonseca
Elena Fonseca
MEMiren Ettcheto
Miren Ettcheto
Elena Sánchez LópezElena Sánchez López
Elena Sánchez López
IRItziar de Rojas
Itziar de Rojas
ARAgustín Ruiz
Agustín Ruiz
Epilepsy is a chronic disease of the central nervous system characterized by an electrical imbalance in neurons. It is the second most prevalent neurological disease, with 50 million people affected around the world, and 30% of all epilepsies do not respond to available treatments. Currently, the main hypothesis about the molecular processes that trigger epileptic seizures and promote the neurotoxic effects that lead to cell death focuses on the exacerbation of the glutamate pathway and the massive influx of Ca2+ into neurons by different factors. However, other mechanisms have been proposed, and most of them have also been described in other neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, or multiple sclerosis. Interestingly, and mainly because of these common molecular links and the lack of effective treatments for these diseases, some antiseizure drugs have been investigated to evaluate their therapeutic potential in these pathologies. Therefore, in this review, we thoroughly investigate the common molecular pathways between epilepsy and the major neurodegenerative diseases, examine the incidence of epilepsy in these populations, and explore the use of current and innovative antiseizure drugs in the treatment of refractory epilepsy and other neurodegenerative diseases.

28 August 2020 in Epilepsia
Verified
Journal Article
Closed access
PDF file
LALaura Abraira
Laura Abraira
ESEstevo Santamarina
Estevo Santamarina
SCSonia Cazorla
Sonia Cazorla
ABAlejandro Bustamante
Alejandro Bustamante
MQManuel Quintana
Manuel Quintana
JSJosé Alvarez Sabín
José Alvarez Sabín

1 January 2020 in Epilepsy & Behavior
Verified
Journal Article
Closed access
EFElena Fonseca
Elena Fonseca
LGLorena Guzmán
Lorena Guzmán
MQManuel Quintana
Manuel Quintana
LALaura Abraira
Laura Abraira
ESEstevo Santamarina
Estevo Santamarina
MTManuel Toledo
Manuel Toledo

1 July 2019 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
LALaura Abraira
Laura Abraira
MTManuel Toledo
Manuel Toledo
LGLorena Guzmán
Lorena Guzmán
MSMaría Sueiras
María Sueiras
MQManuel Quintana
Manuel Quintana
ESEstevo Santamarina
Estevo Santamarina

18 December 2018 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
MRManuel Requena
Manuel Requena
EFElena Fonseca
Elena Fonseca
MOMarta Olivé
Marta Olivé
LALaura Abraira
Laura Abraira
MQManuel Quintana
Manuel Quintana
ESEstevo Santamarina
Estevo Santamarina